EPISODE · Mar 31, 2025 · 13 MIN
Video 2: MDT perspectives on communicating ADC treatment toxicities to patients with metastatic breast cancer
from touchPODCAST · host touchpodcast
Listen to key experts from a multidisciplinary team discuss effective strategies for communicating the potential side effects associated with ADC treatment to patients with metastatic breast cancer. The multidisciplinary team Medical oncologist: Dr Véronique Diéras, Centre Eugène Marquis, Rennes, France Nurse practitioner: Dr Kayla Freeman, Emory Winship Cancer Institute, Atlanta, GA, USA Patient advocate: Mrs Lesley Turner, Independent Cancer Patients’ Voice, UK This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Gilead Sciences, Inc. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: www.touchONCOLOGY.com
Embed this episode
Ready to play
Video 2: MDT perspectives on communicating ADC treatment toxicities to patients with metastatic breast cancer
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.